Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history shows a new revision v3.4.2 has been added, and the prior notices and revision v3.4.1 were removed or superseded. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedThe site added a government funding notice banner and updated the version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedUI/UIX updates to the Record History: a Show glossary option, color-coded additions/deletions, and revised revision labeling. These do not modify core study data or actionable information.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page history shows a new site revision, v3.3.4, replacing v3.3.3, which is an administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include a new revision label (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe Record History now shows Revision: v3.3.2 as the current version, replacing v3.3.1. No study details or page behavior appear to be affected.SummaryDifference0.1%

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.